More modest associations with outcome were found for PTX3, ePCR, PARC and vWF, with high levels of PTX3 and PARC associated with worse progression free survival (LC and COPD and total LC, respectively), and high ePCR associated with better overall survival in patients with LC without COPD. Here, PTX3 is linked to laryngotracheoesophageal cleft.